Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.

Behavioural brain research - 26 Jul 2022

Pathak Piyush, Mehra Aseem, Ram Sant, Pal Arnab, Grover Sandeep

Abstract excerpt

BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders and only less than 50% of MDD patients achieve remission after the first antidepressant trial. Hence, it is important to understand the factors associated with response to various antidepressant medications. Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family. BDNF and Val66Met polymorphism in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antidepressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain-Derived Neurotrophic Factor

Share to Depressive Disorder, Major

Share to Genotype

Share to Nerve injury and regeneration

Share to Polymorphism, Single Nucleotide

Share to Treatment of Major Depression

Source

Identifiers

PMID: 35605794
DOI: 10.1016/j.bbr.2022.113931

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.PMID 35605794Read ↗

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.Semantic proximity Read ↗

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.Semantic proximity Read ↗

Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.Semantic proximity Read ↗

The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.Semantic proximity Read ↗

Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.Semantic proximity Read ↗

Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis.Semantic proximity Read ↗

Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.Semantic proximity Read ↗

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.Semantic proximity Read ↗

BDNF Val66Met Variant as a Genetic Risk Factor for Major Depressive Disorder in Saudis.Semantic proximity Read ↗

Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patientsSemantic proximity Read ↗

BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.